导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 34.53% | 126/1050 |
| 近一周 | 0.61% | 212/1104 |
| 近一月 | -2.20% | 394/1103 |
| 近一季 | -3.12% | 400/1092 |
| 近半年 | 23.82% | 132/1070 |
| 近一年 | 33.23% | 152/1018 |
| 近两年 | 88.99% | 248/926 |
| 近三年 | 63.82% | 194/834 |
| 成立以来 | 48.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.73% 155/1070 |
59.86% 179/1101 |
- - |
- - |
| 2025 | 23.61% 606/1065 |
7.97% 228/1014 |
5.79% 254/1038 |
12.90% 783/1050 |
-4.15% 674/1065 |
| 2024 | 13.39% 209/1011 |
1.49% 235/960 |
7.89% 37/983 |
15.57% 199/991 |
-10.40% 914/1011 |
| 2023 | -22.79% 741/952 |
-1.94% 709/880 |
-8.65% 717/895 |
-4.83% 294/915 |
-9.43% 834/952 |
| 2022 | -17.49% 237/867 |
-16.69% 346/773 |
13.74% 155/806 |
-23.62% 793/845 |
14.00% 44/867 |
| 2021 | -19.72% 531/740 |
-1.05% 193/580 |
8.81% 390/659 |
-14.02% 589/704 |
-13.27% 674/740 |
| 2020 | 62.30% 180/554 |
-2.56% 225/419 |
30.31% 128/466 |
15.48% 138/517 |
10.69% 342/554 |
| 2019 | 24.91% 310/410 |
14.00% 1017/1146 |
-3.23% 593/1228 |
1.94% 280/390 |
11.08% 132/410 |
| 2018 | -27.76% 188/349 |
- - |
-3.25% 147/990 |
-7.28% 601/1000 |
-15.19% 884/1080 |
| 2017 | 32.57% 32/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 广发沪港深新机遇股票 VS. 东吴新产业精选股票A(580008) |